• Improving Patient 
    Outcomes in
    Solid Tumor
    Cancer Treatment

    BIO300
    A New Class of Cancer Drug

  •  

    COVID-19

     

    BIO300
    Preventing long term lung damage caused by inflammation

  • Keeping America Safe

    BIO300
    Protecting Civilians, First Responders and Our Military
    from Nuclear Accidents and Terrorism

Humanetics News

06.02.2021

Humanetics Corporation Receives Funding from Regenerative Medicine Minnesota to Study New Drug for Triple Negative Breast Cancer
Read More

01.25.2021

Humanetics Corporation Receives Funding from Department of Defense to Test Drug Against COVID-19
Read More

10.20.2020

Humanetics Corporation Presents New Data at the Radiation Research Society Meeting
Read More

10.08.20

Humanetics Board Member Vice Admiral Matthew L. Nathan, M.D. Talks with KTTV TV in Los Angeles about COVID-19's Lingering Effects and BIO 300's Clinical Trial
Watch the Interview

10.08.20

MassLive.com Interviews Humanetics Board Member Vice Admiral Matthew L. Nathan, M.D. about BIO 300 and Linking Radiation to Coronavirus in Effort to Help "Long Haulers"
Read the Article

10.06.20

Spectrum News 14 Speaks to Humanetics Board Member Vice Admiral Matthew L. Nathan, M.D. about BIO 300
Watch the Interview

10.01.20

Humanetics Board Member Vice Admiral Matthew L. Nathan, M.D. discusses BIO 300 and Treating COVID "Long Haulers" with WRAZ TV
Watch the Interview

09.29.20

Humanetics CEO Ron Zenk Talks to the Sun Current about BIO 300's Post-COVID-19 Lung Trial
Read More

09.15.20

Matthew L. Nathan, M.D., Former Surgeon General of the U.S. Navy, Joins Board of Directors
Read More

07.23.20

Humanetics CEO Ron Zenk Previews Upcoming BIO 300 COVID-19 Clinical Trial with WCCO TV
Watch the Interview

07.23.20

Humanetics Corporation Receives Funding from NIAID to Test BIO 300 in COVID-19 Patients
Read More

05.28.20

Humanetics Corporation Invited for Oral Presentation at Annual Meeting of American Society of Radiation Oncologists
Read More

02.19.20

Humanetics Acquires Manufacturing Assets for Radioprotectant Drug
Read More

05.06.20

Dr. Colin Chinn, Former Staff Surgeon, Joins Medical Advisory Board
Read More

01.25.2021

Humanetics Corporation Receives Funding from Department of Defense to Test Drug Against COVID-19
Read More